Anti-CD20-Therapie zur Remissionsinduktion und -erhaltung bei therapierefraktärem systemischen Lupus erythematodes

Author:

Chehab G.,Sander O.,Fischer-Betz R.,Schneider M.

Publisher

Springer Science and Business Media LLC

Subject

Rheumatology

Reference21 articles.

1. Bencivelli W, Vitali C, Isenberg DA et al. (1992) Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. III. Development of a computerised clinical chart and its application to the comparison of different indices of disease activity. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 10: 549–554

2. Braendstrup P, Bjerrum OW, Nielsen OJ et al. (2005) Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura. Am J Hematol 78: 275–280

3. Chan O, Shlomchik MJ (1998) A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice. J Immunol 160: 51–59

4. Chan OT, Hannum LG, Haberman AM et al. (1999) A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 189: 1639–1648

5. Cohen AS, Canoso JJ (1972) Criteria for the classification of systemic lupus erythematosus–status 1972. Arthritis Rheum 15: 540–543

Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Clinical value of autoantibodies for lupus myelitis and its subtypes: A systematic review;Seminars in Arthritis and Rheumatism;2018-10

2. Systemischer Lupus erythematodes;Therapie-Handbuch Grundwerk inkl 6. Lfg.;2015

3. Is rituximab effective for induction of remission in lupus nephritis?;Medwave;2014-08-26

4. Beyond the LUNAR trial. Efficacy of rituximab in refractory lupus nephritis;Nephrology Dialysis Transplantation;2012-07-03

5. Rituximab;Rheumatology;2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3